A paper published August 24 at Org. Process Res. Dev by Professor Sean M. Kell et al. describes a robust and efficient continuous flow process technique for the synthesis of quinazoline organozinc reagents for KRAS G12C inhibitor divarasib.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
